9 results for author:"Kozisek M." in Literature citations
Results Customize
› Repeat search in UniProtKB (5)
| Mutations in HIV-1 gag and pol compensate for the loss of viral fitness caused by a highly mutated protease. Kozisek M., Henke S., Saskova K.G., Jacobs G.B., Schuch A., Buchholz B., Muller V., Krausslich H.G., Rezacova P., Konvalinka J. et al. Antimicrob. Agents Chemother. 56:4320-4330(2012) · UniProtKB (2) · Mapped (1) |
| Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes. Rezacova P., Pokorna J., Brynda J., Kozisek M., Cigler P., Lepsik M., Fanfrlik J., Rezac J., Grantz Saskova K., Sieglova I. et al. J. Med. Chem. 52:7132-7141(2009) · Mapped (1) |
| Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavir. Saskova K.G., Kozisek M., Rezacova P., Brynda J., Yashina T., Kagan R.M., Konvalinka J. J. Virol. 83:8810-8818(2009) · Mapped (2) |
| Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir. Saskova K.G., Kozisek M., Lepsik M., Brynda J., Rezacova P., Vaclavikova J., Kagan R.M., Machala L., Konvalinka J. Protein Sci. 17:1555-1564(2008) · Mapped (1) |
| Crystal structures of the effector-binding domain of repressor central glycolytic gene regulator from Bacillus subtilis reveal ligand-induced structural changes upon binding of several glycolytic intermediates. Rezacova P., Kozisek M., Moy S.F., Sieglova I., Joachimiak A., Machius M., Otwinowski Z. Mol. Microbiol. 69:895-910(2008) · UniProtKB (1) |
| Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region. Kozisek M., Saskova K.G., Rezacova P., Brynda J., van Maarseveen N.M., De Jong D., Boucher C.A., Kagan R.M., Nijhuis M., Konvalinka J. J. Virol. 82:5869-5878(2008) · UniProtKB (1) |
| Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations. Kral V., Mader P., Collard R., Fabry M., Horejsi M., Rezacova P., Kozisek M., Zavada J., Sedlacek J., Rulisek L. et al. |
| Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants. Kozisek M., Bray J., Rezacova P., Saskova K., Brynda J., Pokorna J., Mammano F., Rulisek L., Konvalinka J. J. Mol. Biol. 374:1005-1016(2007) · Mapped (1) |
| From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease. Cigler P., Kozisek M., Rezacova P., Brynda J., Otwinowski Z., Pokorna J., Plesek J., Gruner B., Doleckova-Maresova L., Masa M. et al. Proc. Natl. Acad. Sci. U.S.A. 102:15394-15399(2005) · Mapped (1) |